HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter R Galle Selected Research

Tyrosine Kinase Inhibitors

1/2023Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
1/2021Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.
3/2012Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
1/2011AFP measurement in monitoring treatment response of advanced hepatocellular carcinoma to sorafenib: case report and review of the literature.
10/2008Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A.
3/2008PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter R Galle Research Topics

Disease

91Neoplasms (Cancer)
02/2024 - 04/2003
78Hepatocellular Carcinoma (Hepatoma)
06/2024 - 12/2005
27Colorectal Neoplasms (Colorectal Cancer)
05/2021 - 01/2003
25Inflammation (Inflammations)
03/2024 - 02/2003
24Fibrosis (Cirrhosis)
04/2023 - 01/2006
24Infections
02/2023 - 04/2002
20Liver Diseases (Liver Disease)
03/2024 - 01/2003
20Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 09/2006
19Crohn Disease (Crohn's Disease)
01/2019 - 01/2002
17Liver Neoplasms (Liver Cancer)
12/2023 - 07/2006
14Colitis
01/2019 - 01/2002
13Neoplasm Metastasis (Metastasis)
01/2024 - 09/2003
11Adenocarcinoma
01/2024 - 07/2006
10Non-alcoholic Fatty Liver Disease
08/2023 - 04/2006
10Stomach Neoplasms (Stomach Cancer)
01/2019 - 09/2003
10Ulcerative Colitis
07/2018 - 04/2003
9Hepatitis
04/2023 - 07/2004
9Chronic Hepatitis C
11/2018 - 04/2002
9Hepatitis C
10/2018 - 07/2007
9Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2018 - 09/2004
8Hepatic Encephalopathy
12/2023 - 01/2019
8Autoimmune Hepatitis
07/2023 - 03/2003
7Carcinoma (Carcinomatosis)
01/2024 - 01/2008
7Colonic Neoplasms (Colon Cancer)
06/2014 - 04/2003
7Carcinogenesis
06/2012 - 07/2005
6Hypertension (High Blood Pressure)
12/2023 - 01/2013
6Ascites
10/2022 - 05/2013
6Hemorrhage
01/2022 - 07/2004
6Chronic Hepatitis B
08/2021 - 04/2002
6COVID-19
04/2021 - 01/2020
6Asthma (Bronchial Asthma)
06/2007 - 01/2002
5Insulin Resistance
03/2024 - 06/2011
5Disease Progression
11/2023 - 11/2002
5Liver Failure
01/2018 - 05/2004
5Diarrhea
10/2017 - 01/2003
5Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2013 - 08/2008
4Portal Hypertension
04/2023 - 01/2021
4End Stage Liver Disease
04/2023 - 05/2015
4Cholangiocarcinoma
06/2022 - 07/2006
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 06/2011
4Sepsis (Septicemia)
12/2020 - 07/2006
4Reinfection
12/2018 - 01/2006
4Esophageal Neoplasms (Esophageal Cancer)
09/2010 - 10/2006

Drug/Important Bio-Agent (IBA)

29Sorafenib (BAY 43-9006)FDA Link
06/2024 - 07/2008
22CytokinesIBA
02/2024 - 01/2002
22Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2005
17Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2009
15Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2003
15Antiviral Agents (Antivirals)IBA
08/2021 - 04/2002
14Messenger RNA (mRNA)IBA
12/2022 - 01/2002
12atezolizumabIBA
10/2023 - 01/2020
12AntibodiesIBA
04/2021 - 10/2006
11Bevacizumab (Avastin)FDA Link
10/2023 - 01/2020
11RamucirumabIBA
12/2022 - 01/2019
10alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2022 - 09/2013
9Transcription Factors (Transcription Factor)IBA
12/2016 - 01/2002
8Ribavirin (Virazole)FDA LinkGeneric
11/2018 - 04/2002
8Chemokine ReceptorsIBA
07/2011 - 03/2005
8Transforming Growth Factor beta (TGF-beta)IBA
07/2008 - 02/2003
7AlbuminsIBA
10/2023 - 01/2015
7InterferonsIBA
04/2023 - 04/2002
7EnzymesIBA
01/2022 - 03/2004
6AutoantibodiesIBA
06/2023 - 11/2005
6Tyrosine Kinase InhibitorsIBA
01/2023 - 03/2008
6Fluorouracil (Carac)FDA LinkGeneric
03/2013 - 01/2003
6LigandsIBA
03/2013 - 03/2005
6Irinotecan (Camptosar)FDA LinkGeneric
06/2012 - 01/2003
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2011 - 11/2002
5Immune Checkpoint InhibitorsIBA
02/2024 - 01/2020
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2023 - 05/2015
5BilirubinIBA
10/2023 - 02/2016
5Fetal Proteins (Fetoprotein)IBA
12/2022 - 01/2017
5Insulin (Novolin)FDA Link
03/2022 - 04/2006
5Phosphotransferases (Kinase)IBA
06/2014 - 07/2007
5ErbB Receptors (EGF Receptor)IBA
09/2012 - 07/2006
5Azathioprine (Imuran)FDA LinkGeneric
04/2010 - 04/2003
4Cadherins (E-Cadherin)IBA
01/2024 - 01/2019
4AntigensIBA
07/2023 - 09/2006
4Interleukin-23 (Interleukin 23)IBA
01/2023 - 09/2003
4RNA (Ribonucleic Acid)IBA
08/2022 - 06/2013
4Transaminases (Aminotransferases)IBA
01/2022 - 03/2016
4LipidsIBA
01/2021 - 06/2011
4C-Reactive ProteinIBA
01/2021 - 11/2005
4CarbohydratesIBA
07/2020 - 06/2011
4Cetuximab (Erbitux)FDA Link
06/2017 - 07/2006
4Chemokine CXCL12IBA
06/2016 - 03/2005
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2016 - 03/2008
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2013 - 01/2004
4SteroidsIBA
01/2013 - 09/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2011 - 08/2010
4tyrosine receptor (receptor, tyrosine)IBA
09/2010 - 07/2007
4Platelet-Derived Growth Factor alpha ReceptorIBA
03/2010 - 03/2008
4OxazoloneIBA
09/2009 - 12/2002

Therapy/Procedure

88Therapeutics
12/2023 - 01/2003
25Liver Transplantation
04/2023 - 07/2004
15Drug Therapy (Chemotherapy)
12/2022 - 01/2003
13Immunotherapy
02/2024 - 04/2012
12Lasers (Laser)
12/2022 - 09/2004
5Ligation
04/2021 - 08/2006
4Transplantation
01/2019 - 03/2004